Phase III Study of NRD101: A confirmatory study of NRD101 in patients with knee osteoarthritis
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 22 May 2018
At a glance
- Drugs Hyaluronic acid (Primary)
- Indications Osteoarthritis
- Focus Therapeutic Use
- Sponsors Chugai Pharmaceutical
- 16 May 2018 Status changed from recruiting to active, no longer recruiting.
- 10 Jul 2017 Status changed from not yet recruiting to recruiting.
- 24 Mar 2017 New trial record